Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
暂无分享,去创建一个
C. Coutant | C. Touboul | S. Bendifallah | E. Daraï | P. Collinet | M. Ballester | L. Ouldamer | G. Canlorbe | V. Lavoué | O. Graesslin | E. Raimond
[1] J. Ledermann,et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.
[2] E. Lengyel,et al. Patterns and utility of routine surveillance in high grade endometrial cancer. , 2015, Gynecologic oncology.
[3] C. Coutant,et al. Just how accurate are the major risk stratification systems for early-stage endometrial cancer? , 2015, British Journal of Cancer.
[4] A. Althouse,et al. USA endometrial cancer projections to 2030: should we be concerned? , 2014, Future oncology.
[5] S. Rose,et al. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer. , 2014, Gynecologic oncology.
[6] B. Weigelt,et al. Classification of endometrial carcinoma: more than two types. , 2014, The Lancet. Oncology.
[7] C. Coutant,et al. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion , 2014, British Journal of Cancer.
[8] Kathleen R. Cho,et al. Uterine neoplasms, version 1.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] R. Barakat,et al. Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment , 2013, International Journal of Gynecologic Cancer.
[10] R. Gelber,et al. Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Richard G. Moore,et al. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. , 2013, Gynecologic oncology.
[12] A. Mariani,et al. Patterns of Recurrence in Stage I Endometrioid Endometrial Adenocarcinoma With Lymphovascular Space Invasion , 2013, International Journal of Gynecologic Cancer.
[13] M. Kattan,et al. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. , 2012, Gynecologic oncology.
[14] L. Landrum,et al. Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? , 2012, Gynecologic Oncology.
[15] E. Anteby,et al. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[16] F Landoni,et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] C. Haie-meder,et al. Clinical Practice Guidelines for the Management of Patients With Endometrial Cancer in France: Recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique , 2011, International Journal of Gynecologic Cancer.
[18] A. Gadducci,et al. Surveillance Procedures for Patients Treated for Endometrial Cancer: A Review of the Literature , 2010, International Journal of Gynecologic Cancer.
[19] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[20] S. Pecorelli. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .
[21] T. Oliver,et al. Follow-up after primary therapy for endometrial cancer: a systematic review. , 2006, Gynecologic oncology.
[22] M. Maiman,et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .
[23] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.
[24] J. Sorosky,et al. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. , 1992, Gynecologic oncology.
[25] J. V. Bokhman. Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.
[26] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[27] C. Coutant,et al. External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study. , 2015, American journal of obstetrics and gynecology.
[28] B. Glimelius,et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.